Table 2

Baseline characteristics by sex and country in matched cohorts

IndiaUSA
FemalesMalesp ValueFemalesMalesp Value‡
n*1356 (18.1)6149 (81.9)<0.053141 (33.2)6307 (66.8)<0.05
Age*31.2±2232.4±180.6459.6±2348.8±210.49
ISS*11±612±80.198±78±70.15
GCS*12±312±30.1214±114±10.02
Blunt injury*1349 (95.5)5829 (94.8)<0.051329 (98.1)5842 (92.6)<0.05
Penetrating injury*7 (4.5)320 (5.2)<0.0527 (1.9)465 (7.4)<0.05
Surgery*318 (23.4)1892 (30.8)<0.05301 (9.6)385 (4.7)<0.05
Ventilation days*0.1±0.81.5±7.60.100.3±20.6±2.80.05
ICU days*0.2±8.11.7±4.70.230.9±2.71.3±4.00.07
Hospital LOS*2.9±6.59.0±14.80.264.5±5.14.8±7.10.13
In-hospital death*382 (28.2)1610 (26.2)0.1378 (2.5)206 (3.3)0.04
  • Numbers reported as mean ± SD or count (percentage).

  • 2 test for association between variable and gender and Wilcoxon rank-sum test for difference in means between genders within each country. p Value deemed significant at alpha level<0.05.

  • GCS, Glasgow Coma Score; ICU, Intensive Care Unit; ISS, Injury Severity Score; LOS, length of stay; RTS, Revised Trauma Score.